Oxidative Stress In Exercise: Possible New Target For Therapeutic Intervention | 2966
Journal of Computer Science & Systems Biology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The development of an effective vaccine against tuberculosis would be a significant step in tackling the pandemic
currently faced and is a key goal for numerous research groups worldwide. A major hurdle to this development is the lack
of biological markers indicative of protective immunity for tuberculosis (correlates of protection). Non-human primates
potentially represent the most relevant model for evaluation of new vaccines because of the close similarities to human
tuberculosis infection, particularly in the immune responses and disease pathology induced.
To identify potential correlates of protection, RNA from PPD-stimulated peripheral blood mononuclear cells
taken from BCG-vaccinated and unvaccinated cynomolgus macaques before and after tuberculosis challenge, was analysed
using a genome-wide macaque microarray. Differentially expressed (DE) genes were identified and related to the ability to
control progression of TB-induced disease.
825 genes were DE across all groups i.e. vaccinated or unvaccinated animals able to control disease progression
and unvaccinated animals in which disease progressed, representing a common response to tuberculosis infection. 327 genes
were DE in animals which controlled disease progression, regardless of vaccination status and164 genes were DE only in
vaccinated animals which successfully controlled disease, indicating a potential vaccine-induced protective response. Animals
unable to control disease progression exhibited an additional 2086 DE genes after challenge, possibly associated with an overall
lack of control in response to infection.
Using a genome-wide microarray to analyse the expression of thousands of genes simultaneously
provides an unbiased approach to identifying potential biomarkers of disease and protection.
Alice Hicks is in the final year of her PhD with the Health Protection Agency and St George?s University of London, having previously worked with microarrays in the Diagnostic Technologies department. Alice gained her Masters degree in Medical and Molecular Microbiology in 2007 from University of Manchester, UK, where she came top of her class.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals